首页> 外国专利> A process for preparing N dihydrolysergol-alkylcarbaminsyreestere of I and 1-methyl-dihydrolysergol I.

A process for preparing N dihydrolysergol-alkylcarbaminsyreestere of I and 1-methyl-dihydrolysergol I.

机译:一种制备I和1-甲基-二氢麦角甾醇I的N-二氢麦角酚-烷基氨基甲酸酯基酯的方法。

摘要

The invention c omprises ergoline I derivatives of the general formula F1 wherein, when R is a hydrogen atom, R1 is an acyl radical of an alkanoic or carbomoic carboxylic acid having from 3-10 carbon atoms or an unsubstituted aromatic or a pyridine carboxylic acid, and, when R is a methyl group, R1 is a hydrogen atom or an acyl radical as just defined, and the preparation thereof by esterification of the corresponding 8-hydroxymethy-ergoline I derivative with the appropriate acid halide or anhydride; the 1,6dimethyl -8-hydroxymethyl-ergoline I being prepared by reaction in liquid ammonia of methyl iodide with the potassium salt of the 6-methyl8-hydroxymethyl-ergoline I which is itself prepared by reduction with lithium aluminium hydride of an ester of dihydrolysergic acid. Therapeutic compositions for oral or parenteral administration, having oxytocic, antienteraminic, andrenolytic, hypotensive and sedative activity, comprise a compound of the above general formula and an excipient or diluent. Reference has been directed by the Comptroller to Specification 1,008,466.
机译:本发明包含通式的麦角灵I衍生物,其中,当R是氢原子时,R1是具有3-10个碳原子的链烷或羰基羧酸或未取代的芳族化合物或吡啶羧酸,并且当R是甲基时,R1是氢原子或如上定义的酰基,其通过将相应的8-羟基甲基麦角灵I衍生物与合适的酰卤或酸酐酯化而制备; 1,6-二甲基-8-羟甲基-麦角灵Ⅰ是通过在碘甲烷的液态氨中与6-甲基8-羟甲基-麦角灵Ⅰ的钾盐反应而制得的,而6-甲基8-羟甲基-麦角灵Ⅰ本身是通过用氢化铝锂还原二氢麦角酸的酯而制备的。酸。具有催产,抗肠胃药,肾上腺素能,降压和镇静作用的口服或肠胃外给药的治疗组合物包含上述通式的化合物和赋形剂或稀释剂。主计长已对规范1008466进行了引用。

著录项

  • 公开/公告号DK104939C

    专利类型

  • 公开/公告日1966-07-25

    原文格式PDF

  • 申请/专利权人 SOCIETA FARMACEUTICI ITALIA;

    申请/专利号DK19630003528

  • 发明设计人

    申请日1963-07-24

  • 分类号1C07DA;

  • 国家 DK

  • 入库时间 2022-08-23 15:20:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号